Fig. 5From: Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitorsTime courses of relative cell counts after a drug treatment in different concentrations. Panc 04.03 treated with (A) JNJ-7706621 and (D) PP1, DU 145 treated with (B) AZD6482 and (E) XMD8–92, and HCC70 treated with (C) GW2580 and (F) PI-103Back to article page